Explore more by category
Period
Filter by
recent search
Showing: 1 – 5 of 216 stories
21 May 2026 – 0 mins read
Driving Progress in Rare Liver Disease: Ipsen at EASL Congress 2026
We’re excited to be at the European Association for the Study of the Liver (EASL) Congress 2026, Europe’s largest event dedicated to liver health where doctors, scientists, allied health professionals, patients, and industry partners come together to share knowledge, highlight scientific breakthroughs, and build meaningful connections.
19 May 2026 – 2 mins read
A moment worth remembering: what SCALE tells us about the future of aesthetics
There are moments that stay with you. Not because of a single slide or headline, but because you can feel something changing. Expectations shift. Standards rise. A new chapter begins.
19 May 2026 – 1 mins read
Driven by patients, delivering on our strategy: 2025 Integrated Annual Report now available
Ipsen’s 2025 Integrated Annual report report is now available on Ipsen.com. This essential reference document brings together key information and insights into the major developments in 2025 and what lies ahead.
15 May 2026 – 1 mins read
Right medicine, right person: Jacintha Sivarajah on science with purpose
“All medicines have side effects, but it’s just about trying to minimize the impact through providing the information patients and clinicians need or finding other ways to mitigate that impact.” — Jacintha Sivarajah
14 May 2026 – 2 mins read
Aesthetics, built from science
Ipsen is not new to aesthetics. For more than three decades, we have been advancing neuroscience innovations across therapeutic and aesthetic indications, building deep expertise in complex biologics, rigorous clinical development and high‑quality manufacturing.



